Press-release for stocks related to treatment

Prices are updated after-hours

tags : Treatment source : Www.prnewswire.com

save search

Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K

Manufacturing

| Email alert Add to watchlist
ALPMF | News | $9.75 43.47% 200

Health Technology

| Email alert Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M

Health Technology

| Email alert Add to watchlist
granted approval cancer treatment for

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)
Published: 2024-04-23 (Crawled : 07:00) - prnewswire.com
ONTX | $0.9953 -5.61% 1.3M

Health Technology

| Email alert Add to watchlist
publication treatment research preclinical for leukemia

Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M

Health Technology

| 1.75% | O: 0.42% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| 4.79% | O: 0.82% H: 0.0% C: 0.0%
MIRM | $24.4 0.95% 0.94% 420K

Health Technology

| 3.61% | O: -0.68% H: 2.52% C: 1.71%
report million reach treatment market

NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published: 2024-04-17 (Crawled : 12:00) - prnewswire.com
NRBO | $3.05 -2.24% -2.3% 42K

Health Technology

| -11.18% | O: 8.53% H: 0.0% C: -6.23%
da-1726 obesity first treatment pharmaceuticals for trial

Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 2.32% | O: 0.12% H: 0.51% C: 0.51%
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 3.1% | O: -0.04% H: 0.28% C: -0.16%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| 3.97% | O: 1.05% H: 0.0% C: 0.0%
treatment global growth market

Fracking Water Treatment Market size to record USD 1.20 billion growth from 2023-2027, Adoption of supercritical carbon in fracking is one of the key market trends, Technavio
Published: 2024-04-16 (Crawled : 23:00) - prnewswire.com
XYL | News | $130.72 1.35% 0.0% 950K

Producer Manufacturing

| 2.13% | O: 0.38% H: 0.0% C: -1.77%
water one treatment key growth market

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | News A | $11.36 0.98% 0.97% 4.7M

Health Technology

| 0.35% | O: -0.53% H: 0.0% C: -1.24%
NVS | News | $97.28 2.27% 0.31% 3.7M

Health Technology

| 3.27% | O: -1.46% H: 0.0% C: 0.0%
PHG | News | $21.01 1.94% 0.0% 2M

Health Technology

| 1.64% | O: -1.21% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M

Health Technology

| 1.83% | O: -1.19% H: 0.52% C: -0.17%
VRNA | $15.6 -0.76% -0.77% 360K

Health Technology

| -1.33% | O: 1.65% H: 2.43% C: 0.87%
reach treatment research market

Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid Misuse, Addiction, and/or Overdose
Published: 2024-04-15 (Crawled : 20:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 0.95% | O: -2.09% H: 0.0% C: 0.0%
opioid million treatment for

Euro Tech Holdings Company Limited Reported An Exclusive Sales Distribution And OEM Partnership Agreement Covering Ballast Water Treatment Systems ("BWTS") Has Been Signed Between PACT And ERMA FIRST
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
CLWT | $1.54 0.0% 480

Electronic Technology

| 0.0% | O: 1.1% H: 0.19% C: 0.19%
sales water partnership first company distribution treatment agreement

A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born
Published: 2024-04-15 (Crawled : 10:00) - prnewswire.com
NCTY | $6.44 3.04% 2.95% 21K

Technology Services

| 3.66% | O: -4.94% H: 0.0% C: 0.0%
drug precision treatment technology

Soil Treatment Market size is set to grow by USD 16.46 billion from 2023-2027, Need to meet rising demand for crops boost the market, Technavio
Published: 2024-04-10 (Crawled : 13:30) - prnewswire.com
CODYY | $15.0 -0.13% 750K

Manufacturing

| -5.57% | O: -3.01% H: 1.44% C: 0.84%
treatment for set market

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
Published: 2024-04-10 (Crawled : 10:00) - prnewswire.com
TBPH | $9.21 -2.64% -2.71% 340K

Health Technology

| -2.74% | O: -1.37% H: 2.14% C: 2.03%
treatment system for key potential

Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Published: 2024-04-09 (Crawled : 12:30) - prnewswire.com
GNPX | $2.32 7.26% 6.77% 30K

Health Technology

| -21.96% | O: 2.36% H: 6.6% C: 1.32%
reqorsa lung report positive treatment system preclinical for meeting therapy

Jacobs to Design Miami-Dade Wastewater Treatment Plant Expansion and Upgrades
Published: 2024-04-09 (Crawled : 12:00) - prnewswire.com
J | $144.63 0.36% 0.0% 350K

Industrial Services

| -2.54% | O: -0.99% H: 0.22% C: -0.14%
ACM | $93.88 1.57% 0.0% 470K

Industrial Services

| -3.98% | O: 0.24% H: 0.18% C: -1.91%
treatment expansion design

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
Published: 2024-04-08 (Crawled : 12:30) - prnewswire.com
NRXP | $3.1 3.33% 3.23% 110K

Manufacturing

| -41.9% | O: 0.57% H: 7.01% C: 3.79%
nrx-101 depression treatment pharmaceuticals trial

SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
Published: 2024-04-07 (Crawled : 16:20) - prnewswire.com
MDT | $81.29 0.89% 0.0% 5.2M

Health Technology

| Email alert Add to watchlist
EW | $87.75 0.91% 0.0% 2.7M

Health Technology

| Email alert Add to watchlist
treatment for women smart trial platform

CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
Published: 2024-04-06 (Crawled : 04:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| Email alert Add to watchlist
carvykti fda first approved one treatment for therapy

POWERFLEET ANNOUNCES RESTATEMENT OF ACCOUNTING TREATMENT OF LEGACY CONVERTIBLE PREFERRED STOCK INSTRUMENT, WHICH HAS NO ADVERSE IMPACT ON PREVIOUSLY REPORTED REVENUE, CASH FLOW OR ADJUSTED EBITDA
Published: 2024-04-05 (Crawled : 23:00) - prnewswire.com
PWFL | $4.2 3.45% 3.33% 730K

Electronic Technology

| Email alert Add to watchlist
MIXT | $14.55 0.0% 530K

Technology Services

| Email alert Add to watchlist
treatment impact flow

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process
Published: 2024-04-02 (Crawled : 12:30) - prnewswire.com
TCBP | $1.58 6.39% 110K